3-Chloro-4-(trifluoromethyl)benzoic acid, 97.0%, 100g

2,6-Diisopropylbenzaldehyde, 97%, 1g

1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)-N,N-dimethylmethanamine, 95.0%, 5g

Benzyl 3,3-difluoro-4-oxopiperidine-1-carboxylate, 95.0%, 500mg

3-Bromo-2-chloro-5-methylpyridine, 98.0%, 5g

(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-1-pyrrolidinecarboxylic acid tert-butyl ester, 98%, 5g

2-(Thiazol-2-yl)acetonitrile, 95.0%, 100mg

(3-methyl-4,5-dihydro-1H-pyrazol-1-yl)acetic acid hydrochloride, 95.0%, 1g

2,3,5-Trichloropyridine, 98.0%, 25g

3-Bromoisoquinolin-1-amine, 95.0%, 1g

(1R,3R)-METHYL 1-(BENZO[D][1,3]DIOXOL-5-YL)-2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOLE-3-CARBOXYLATE HCL, 98.0%, 25g

(S)-2-Amino-3-(4-hydroxyphenyl)propanamide, 95.0%, 5g

Single-channel microliter pipette Pipetman® L, 0.2 to 2 µl, P2L, 1 piece